Skip to main content

Plerixafor

Details of the Drug
Generic Name:
Plerixafor
Pronunciation:
ple-RIK-sa-fore
Drug Type:
Stem cell mobilizer
How the Drug is Given:

Subcutaneous (SC) injection

Names:
Mozobil®
Plerixafor

Indications and Usage

Plerixafor injection is FDA approved for use along with a granulocyte colony-stimulating factor (G-CSF) medication in preparation for an autologous stem cell transplant in patients with non-Hodgkin lymphoma or myeloma. Plerixafor injection works by causing certain blood cells to move from the bone marrow to the blood so that they can be removed for transplantation.

Side effects needing medical attention

Diarrhea; nausea; tiredness (fatigue); injection site reaction; headache; pain in the joints (arthralgia); dizziness; vomiting. 

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.